NCT02962544

Brief Summary

Aim of the work is to compare the results of femtosecond assisted LASIK and small incision lenticule extraction (SMILE) as regards safety, efficacy and predictability. As a secondary outcomes , the investigators will compare the results of both techniques on corneal biomechanics, dry eye measures, corneal asphericity and higher order aberration.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2015

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

October 24, 2016

Completed
18 days until next milestone

First Posted

Study publicly available on registry

November 11, 2016

Completed
20 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2017

Completed
Last Updated

November 11, 2016

Status Verified

November 1, 2016

Enrollment Period

1.8 years

First QC Date

October 24, 2016

Last Update Submit

November 9, 2016

Conditions

Keywords

FemtosecondSmall incision lenticule extractionLenticule extractionLASIKMyopia

Outcome Measures

Primary Outcomes (3)

  • refractive predictability(manifest refraction spherical equivalent using autorefractometer)

    • Refractive predictability, which is defined as the proportion number of eyes achieving a postoperative spherical equivalent (SE) within ±0.50 D of the intended target.

    change from baseline at 3 months postoperative.

  • efficacy(Unaided distance visual acuity using snellen chart)

    Efficacy: defined as the proportion number of eyes achieving an unaided visual acuity (UDVA) of 20/20 or better postoperatively (efficacy= postoperative UCVA/preoperative BCVA %).

    change from baseline at 3 months postoperative.

  • safety( Corrected distance visual acuity using snellen chart)

    Safety: defined as the proportion number of eyes that lost or gained one or more lines of postoperative best corrected visual acuity (BCVA) relative to the preoperative BCVA (Safety= Postoperative BCVA/preoperative BCVA %)

    change from baseline at 3 months postoperative.

Secondary Outcomes (5)

  • corneal hysteresis

    change from baseline at 3 months postoperative.

  • schirmer test

    change from baseline at 3 months postoperative.

  • corneal higher order aberrations.( total RMS)

    change from baseline at 3 months postoperative.

  • corneal resistance factor

    change from baseline at 3 months postoperative.

  • tear break up time test.

    change from baseline at 3 months postoperative.

Study Arms (2)

Visumax device for FS-SMILE group

ACTIVE COMPARATOR

(FS-SMILE )femtosecond small incision lenticule extraction procedure using Visumax laser device as a surgical intervention for correction of myopia and myopic astigmatism will be done for 30 eyes of patients with myopia or myopic astigmatism.

Procedure: FS-SMILEDevice: Visumax device

FS 200 device for FS-LASIK group

ACTIVE COMPARATOR

(FS-LASIK)femtosecond assisted LASIK procedure using Fs200 laser device as a surgical intervention for correction of myopia and myopic astigmatism will be done for 30 eyes of patients with myopia or myopic astigmatism.

Procedure: FS- LASIKDevice: FS 200 device

Interventions

FS-SMILEPROCEDURE

The procedure will be performed using an established technique. the patient's eye will be centered and docked with the curved interface cone before application of suction fixation.The laser will be activated for photo-dissection in the following sequence: first the posterior surface of the refractive lenticule then the lenticule border then The anterior surface of the refractive lenticule which extended beyond the posterior lenticule diameter by 0.5 mm to form the anterior flap and is followed by a rim cut. After the suction is released, a Siebel spatula is inserted under the cap near the hinge before the cap is separated. The edge of the refractive lenticule is separated from the stromal bed with a sinsky hook and the posterior border of the lenticule gently separated with the Siebel spatula. The lenticule is then grasped with forceps through the small incision.

Visumax device for FS-SMILE group
FS- LASIKPROCEDURE

LASIK procedure Each LASIK procedure will be performed using a standard, established technique. Under topical anesthesia and standard draping, a lid speculum is used to retract the eyelids. A superiorly hinged 100 μm thick flap will be created using the WaveLight FS200 (Alcon Laboratories, Inc.) With inverted side cut (115 ̊) .Excimer laser ablation is then performed using WaveLight EX500 excimer laser (Alcon Laboratories, Inc.).After ablation, the flap will be carefully repositioned, and postoperative medications are commenced.

FS 200 device for FS-LASIK group
Visumax device for FS-SMILE group
FS 200 device for FS-LASIK group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age is 18 years or older.
  • Best corrected visual acuity of 6/6.
  • Manifest refraction spherical equivalent (MRSE) not more than 9diopters (D).
  • Refractive cylinder not more than 3 diopters (D).
  • No topographic evidence of forme frust keratoconus (FFKC).
  • No progressive change of sphere or cylinder more than 0.5 diopter per year.

You may not qualify if:

  • Previous history of ocular trauma or ocular surgery.
  • Concomitant active or previous ocular disease such as uveitis and glaucoma.
  • Systemic diseases affecting wound healing such as diabetes mellitus, collagen vascular diseases
  • Dry eye.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kasr Alainy Hospital

Cairo, 11956, Egypt

RECRUITING

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Officials

  • Mohsen N Salem, MD

    Kasr alainy school of medicine

    STUDY DIRECTOR
  • mohamed H hosny, MD

    Kasr alainy school of medicine

    STUDY DIRECTOR
  • MOHAMED ANIS, MD

    Kasr alainy school of medicine

    STUDY DIRECTOR

Central Study Contacts

Esraa MA El-Mayah, Msc

CONTACT

esraa MA El-Mayah, MSC

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer

Study Record Dates

First Submitted

October 24, 2016

First Posted

November 11, 2016

Study Start

March 1, 2015

Primary Completion

December 1, 2016

Study Completion

February 1, 2017

Last Updated

November 11, 2016

Record last verified: 2016-11

Data Sharing

IPD Sharing
Will not share

Locations